|
|
|
|
|
|
|
|
|
|
|
|
|
30.01.26 - 13:33
|
Avicanna Announces Medical Cannabis Real World Evidence Results and Publication (GlobeNewswire EN)
|
|
|
Prospective observational study reports improvements in pain-related outcomes, mental health measures, and quality of life among patients using physician-authorized medical cannabis in the Canadian Journal of Pain Prospective observational study reports improvements in pain-related outcomes, mental health measures, and quality of life among patients using physician-authorized medical cannabis in the Canadian Journal of Pain...
|
|
|
23.12.25 - 13:33
|
Avicanna Announces Changes to its Board of Directors (GlobeNewswire EN)
|
|
|
TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, announces Mr. Paul Fornazzari's resignation from the Company's board of directors, and is pleased to announce the appointment of Mr. Michael Kott to its board of directors....
|
|
|
|
|
18.12.25 - 02:09
|
ThreeD Capital Inc. Issues Early Warning Report in Connection with Disposition of Securities of Avicanna Inc. (GlobeNewswire EN)
|
|
|
TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD”) (CSE:IDK / OTCQX:IDKFF) a Canadian based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that through a series of transactions ending in recent weeks (the “Dispositions”), ThreeD disposed of ownership and control of an aggregate of 1,130,000 common shares (the “Subject Shares”) of Avicanna Inc. (the “Company” or “AVCN”). The Subject Shares represented approximately 1.0% of all issued and outstanding common shares of AVCN. As a result of the Dispositions, the percentage ownership held by ThreeD and Sheldon Inwentash (the “Joint Actor”) decreased by greater than 2%, on a partially diluted basis, from the last early warning report filed....
|
|
|
|
|
|
|
14.11.25 - 23:33
|
Avicanna Reports Q3 2025 (GlobeNewswire EN)
|
|
|
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce and report the results of Q3 2025....
|
|
|
13.09.25 - 00:03
|
Avicanna Announces Change in CFO (GlobeNewswire EN)
|
|
|
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialisation of plant-derived cannabinoid-based products, is pleased to announce Nick Hilborn, CPA, CA, Vice President of Finance, is appointed Interim Chief Financial Officer, following Phillip Cardella, CPA, CA, transition to consultant effective Monday, September 15, 2025....
|
|
|
|
|
|
|
|
|
14.08.25 - 13:42
|
Avicanna Reports Q2 2025 (GlobeNewswire EN)
|
|
|
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce and report the results of Q2 2025....
|
|
|
|
|
|
|
30.06.25 - 23:33
|
Avicanna Announces Results of Annual General Meeting (GlobeNewswire EN)
|
|
|
TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products is pleased to announce that all of management's nominees listed in the Company's Management Information Circular dated May 27, 2025 (“Circular”) were elected as directors of the Company at the Company's Annual General Meeting of Shareholders held on June 30, 2025 (“Meeting”)....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
